| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| LILLY ENDOWMENT INC | 10%+ Owner | 2801 NORTH MERIDIAN STREET, INDIANAPOLIS | /s/ Diane M. Stenson, Vice President and Treasurer, on behalf of Lilly Endowment Inc. | 24 Nov 2025 | 0000316011 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Sale | $10,367,235 | -9,871 | -0.01% | $1050.27 | 92,597,433 | 21 Nov 2025 | Direct | F1 |
| transaction | LLY | Common Stock | Sale | $5,789,471 | -5,506 | -0.01% | $1051.48 | 92,591,927 | 21 Nov 2025 | Direct | F2 |
| transaction | LLY | Common Stock | Sale | $3,036,061 | -2,885 | -0% | $1052.36 | 92,589,042 | 21 Nov 2025 | Direct | F3 |
| transaction | LLY | Common Stock | Sale | $2,093,221 | -1,987 | -0% | $1053.46 | 92,587,055 | 21 Nov 2025 | Direct | F4 |
| transaction | LLY | Common Stock | Sale | $1,717,653 | -1,629 | -0% | $1054.42 | 92,585,426 | 21 Nov 2025 | Direct | F5 |
| transaction | LLY | Common Stock | Sale | $2,633,353 | -2,495 | -0% | $1055.45 | 92,582,931 | 21 Nov 2025 | Direct | F6 |
| transaction | LLY | Common Stock | Sale | $1,633,188 | -1,546 | -0% | $1056.40 | 92,581,385 | 21 Nov 2025 | Direct | F7 |
| transaction | LLY | Common Stock | Sale | $5,355,605 | -5,064 | -0.01% | $1057.58 | 92,576,321 | 21 Nov 2025 | Direct | F8 |
| transaction | LLY | Common Stock | Sale | $10,297,767 | -9,729 | -0.01% | $1058.46 | 92,566,592 | 21 Nov 2025 | Direct | F9 |
| transaction | LLY | Common Stock | Sale | $25,342,781 | -23,916 | -0.03% | $1059.66 | 92,542,676 | 21 Nov 2025 | Direct | F10 |
| transaction | LLY | Common Stock | Sale | $8,040,946 | -7,582 | -0.01% | $1060.53 | 92,535,094 | 21 Nov 2025 | Direct | F11 |
| transaction | LLY | Common Stock | Sale | $11,137,877 | -10,492 | -0.01% | $1061.56 | 92,524,602 | 21 Nov 2025 | Direct | F12 |
| transaction | LLY | Common Stock | Sale | $9,616,841 | -9,051 | -0.01% | $1062.52 | 92,515,551 | 21 Nov 2025 | Direct | F13 |
| transaction | LLY | Common Stock | Sale | $9,121,193 | -8,576 | -0.01% | $1063.57 | 92,506,975 | 21 Nov 2025 | Direct | F14 |
| transaction | LLY | Common Stock | Sale | $3,595,655 | -3,378 | -0% | $1064.43 | 92,503,597 | 21 Nov 2025 | Direct | F15 |
| transaction | LLY | Common Stock | Sale | $1,554,665 | -1,459 | -0% | $1065.57 | 92,502,138 | 21 Nov 2025 | Direct | F16 |
| transaction | LLY | Common Stock | Sale | $170,584 | -160 | -0% | $1066.15 | 92,501,978 | 21 Nov 2025 | Direct |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,050.00 to $1,050.997, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), and (16) to this Form 4. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,051.00 to $1,051.994, inclusive. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,052.00 to $1,052.96, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,053.00 to $1,053.99, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,054.00 to $1,054.99, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,055.00 to $1,055.969, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,056.00 to $1,056.99, inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,057.00 to $1,057.97, inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,058.022 to $1,059.005, inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,059.034 to $1,060.032, inclusive. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,060.037 to $1,061.036, inclusive. |
| F12 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,061.039 to $1,062.022, inclusive. |
| F13 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,062.043 to $1,063.04, inclusive. |
| F14 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,063.051 to $1,064.042, inclusive. |
| F15 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,064.07 to $1,065.03, inclusive. |
| F16 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,065.118 to $1,066.00, inclusive. |